These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 36061599)
41. CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in Chen X; Lin Y; Zhang Z; Tang Y; Ye P; Dai W; Zhang W; Liu H; Peng G; Huang S; Qiu J; Guo W; Zhu X; Wu Z; Kuang Y; Xu P; Zhou M Neural Regen Res; 2024 Jan; 19(1):196-204. PubMed ID: 37488867 [TBL] [Abstract][Full Text] [Related]
42. Mutation Screening of the CHCHD2 Gene for Alzheimer's Disease and Frontotemporal Dementia in Chinese Mainland Population. Che XQ; Zhao QH; Huang Y; Li X; Ren RJ; Chen SD; Guo QH; Wang G J Alzheimers Dis; 2018; 61(4):1283-1288. PubMed ID: 29376860 [TBL] [Abstract][Full Text] [Related]
43. CHCHD10 is not a frequent causative gene in Chinese ALS patients. Li XL; Shu S; Li XG; Liu Q; Liu F; Cui B; Liu MS; Peng B; Cui LY; Zhang X Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):458-60. PubMed ID: 27077676 [TBL] [Abstract][Full Text] [Related]
44. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity. Woo JA; Liu T; Trotter C; Fang CC; De Narvaez E; LePochat P; Maslar D; Bukhari A; Zhao X; Deonarine A; Westerheide SD; Kang DE Nat Commun; 2017 Jun; 8():15558. PubMed ID: 28585542 [TBL] [Abstract][Full Text] [Related]
45. Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis. Häkkinen S; Chu SA; Lee SE Neurobiol Dis; 2020 Nov; 145():105063. PubMed ID: 32890771 [TBL] [Abstract][Full Text] [Related]
46. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients. Chiò A; Mora G; Sabatelli M; Caponnetto C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Monsurrò MR; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Nilo R; Battistini S; Mandrioli J; Tanel R; Murru MR; Mandich P; Zollino M; Conforti FL; ; Brunetti M; Barberis M; Restagno G; Penco S; Lunetta C Neurobiol Aging; 2015 Apr; 36(4):1767.e3-1767.e6. PubMed ID: 25726362 [TBL] [Abstract][Full Text] [Related]
47. Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c. Meng H; Yamashita C; Shiba-Fukushima K; Inoshita T; Funayama M; Sato S; Hatta T; Natsume T; Umitsu M; Takagi J; Imai Y; Hattori N Nat Commun; 2017 Jun; 8():15500. PubMed ID: 28589937 [TBL] [Abstract][Full Text] [Related]
48. FDA-approved PDE4 inhibitors reduce the dominant toxicity of ALS-FTD-associated Maitra S; Baek M; Choe YJ; Kim NC bioRxiv; 2024 Jun; ():. PubMed ID: 38895204 [TBL] [Abstract][Full Text] [Related]
49. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders. Ogaki K; Koga S; Heckman MG; Fiesel FC; Ando M; Labbé C; Lorenzo-Betancor O; Moussaud-Lamodière EL; Soto-Ortolaza AI; Walton RL; Strongosky AJ; Uitti RJ; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Puschmann A; Nishioka K; Funayama M; Hattori N; Parisi JE; Petersen RC; Graff-Radford NR; Boeve BF; Springer W; Wszolek ZK; Dickson DW; Ross OA Neurology; 2015 Dec; 85(23):2016-25. PubMed ID: 26561290 [TBL] [Abstract][Full Text] [Related]
50. Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Kirola L; Mukherjee A; Mutsuddi M Mol Neurobiol; 2022 Sep; 59(9):5673-5694. PubMed ID: 35768750 [TBL] [Abstract][Full Text] [Related]
51. CHCHD10 and SLP2 control the stability of the PHB complex: a key factor for motor neuron viability. Genin EC; Bannwarth S; Ropert B; Lespinasse F; Mauri-Crouzet A; Augé G; Fragaki K; Cochaud C; Donnarumma E; Lacas-Gervais S; Wai T; Paquis-Flucklinger V Brain; 2022 Oct; 145(10):3415-3430. PubMed ID: 35656794 [TBL] [Abstract][Full Text] [Related]
57. CHCHD10 mutations in patients with amyotrophic lateral sclerosis in Mainland China. Shen S; He J; Tang L; Zhang N; Fan D Neurobiol Aging; 2017 Jun; 54():214.e7-214.e10. PubMed ID: 28318595 [TBL] [Abstract][Full Text] [Related]
58. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease. Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611 [TBL] [Abstract][Full Text] [Related]
59. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations. Liu YT; Huang X; Nguyen D; Shammas MK; Wu BP; Dombi E; Springer DA; Poulton J; Sekine S; Narendra DP Hum Mol Genet; 2020 Jun; 29(9):1547-1567. PubMed ID: 32338760 [TBL] [Abstract][Full Text] [Related]
60. The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients. Wong CH; Topp S; Gkazi AS; Troakes C; Miller JW; de Majo M; Kirby J; Shaw PJ; Morrison KE; de Belleroche J; Vance CA; Al-Chalabi A; Al-Sarraj S; Shaw CE; Smith BN Neurobiol Aging; 2015 Oct; 36(10):2908.e17-8. PubMed ID: 26344877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]